4
Changes in Ownership
Royalty Pharma plc Filed Acc 0001814876-25-000007
EVP & CFO sold 69,582 shares at an average $38.55 ($2,682,505)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Coyne Terrance P. · EVP & CFO
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-11-24 | Sale : show line 1 in the form 10b5-1 | −55,146 | $38.67 | $2,132,292 | 669,010 | I |
| 2025-11-24 | Sale : show line 2 in the form 10b5-1 | −10,686 | $37.96 | $405,645 | 658,324 | I |
| 2025-11-24 | Sale : show line 3 in the form 10b5-1 | −3,126 | $38.67 | $120,882 | 51,634 | I |
| 2025-11-24 | Sale : show line 4 in the form 10b5-1 | −624 | $37.96 | $23,687 | 51,010 | I |
| Open-market sales · 69,582 sh · avg $38.55 · $2,682,505 | ||||||
Loading xslF345X05/wk-form4_1764194502.xml…